CClinicalTrials.gg
CompletedNCT01086202Updated Sep 15, 2016

Clinical Outcome Comparison Between Medial and Lateral Offset Reverse Shoulder Arthroplasty

An observational study in Rotator Cuff Tear, Proximal Humerus Fractures and Malunions, sponsored by Loma Linda University. Completed at 1 site in United States. Open to participants aged 50 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-09-15.

Sponsored by Loma Linda University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
37
Ages
50 Years to 90 Years
Sex
All
01

Study summary

The purpose of this study is to prospectively evaluate two FDA approved implant designs for the Tornier Reverse Shoulder arthroplasty. The small difference in design is the amount of offset each implant has. This offset may improve clinical outcomes in the patient population. There have been no clinical comparative studies between these two designs in the literature to date. We would like to follow these patients for two years after implantation of the reverse shoulder and evaluate their radiographs, pain scores, and shoulder functional scores. this would be the first randomized prospective single blinded study of its kind.

Read the detailed description

The combination of shoulder arthritis and rotator cuff deficiency presents quite a surgical challenge. The reverse prosthesis offers a treatment option for subset of patients as previous attempts to treat with soft tissue reconstruction or conventional arthroplasty have provided sub-optimal clinical results. Numerous reports in the literature have validated the effectiveness of the reverse design.

Patients meeting criteria must be between the ages of 50 and 95 years of age and are a candidate for a reverse shoulder arthroplasty. This is includes patients with rotator cuff tear arthroplasty, irreparable rotator cuff tears, significant proximal humerus fractures and malunions, and chronic proximal humerus dislocators. A total of 40 patients will be enrolled and randomized to either one of two groups; 20 patients will be randomized to the Tornier Reversed shoulder Arthroplasty Medial offset, and 20 will receive the Lateral offset design. Both implants are FDA approved. The patients will be followed for 24 months and will follow-up will be at 6 weeks, 3 months, 6 months, 12 months and 24 months questionnaires will be completed at each visit, x-rays will be done at pre-op, 3 month, 6 months 12 and 24 months.

02

Conditions studied

  • Rotator Cuff Tear
  • Proximal Humerus Fractures
  • Malunions
  • Chronic Proximal Humerus Dislocations

Keywords

  • irreparable rotator cuff tears
03

In context

Rotator Cuff Injuries

734 studies on the registry are indexed under Rotator Cuff Injuries; 161 are open to participants now.

This study's enrollment of 37 is below the median of 67 across 162 observational studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

Loma Linda University is the lead sponsor of 297 studies on the registry; 48 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 23 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Elderly/aged, Inpatient and outpatient, healthy patients, females, males physically handicapped, Seventh-day Adventist cohort.

Inclusion criteria

  1. Any patient that is a candidate for reverse shoulder arthroplasty this includes:
  • rotator cuff tear arthroplasty,
  • irreparable rotator cuff tear,
  • significant proximal humerus fracture and malunions,
  • chronic proximal humerus dislocation.

Exclusion criteria

Exclusion Criteria:

  1. Any patient with previous arthroplasty on affected shoulder.
  2. Patient who will need additional procedures including: bone grafting of the glenoid and muscle transfer.
  3. Patients who do not want to participate or participate in follow-ups.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
37 participants (actual)
Patient registry
No

Groups and cohorts

  • Tornier Reversed Shoulder Arthroplasty Medial Offset
  • Lateral offset arthroplasty
06

What researchers measure

Primary outcomes

  1. Clinical Outcome Comparison Between Medical Lateral Offset Reverse Shoulder Arthroplasty

    We would like to follow these patients for two years after implantation of the reverse shoulder and evaluate their radiographs, pain scores, and shoulder functional scores. this would be the first randomized prospective single blinded study of its kind.

    Time frame: 36 Months

07

Study locations

1 site
  • Loma Linda University Health Care Dept. of Orthopaedic Surgery
    Loma Linda, California 92354, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01086202
Lead sponsor
Loma Linda University
Responsible party
Wesley P. Phipatanakul (M.D. Asscoaite Professor, Loma Linda University) — Principal investigator
First posted
Mar 15, 2010
Start date
May 2010
Primary completion
Sep 2014
Completion
Oct 2014
Last update
Sep 15, 2016

Study contacts

Wesley Phipatanakul, MD
principal investigator · Loma Linda University Health Dept. Orthopaedic Surgery

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion